Revolutionary innovations are underway to industrialize cell and gene therapies
Jun
13
2024
Upcoming webinar

Revolutionary innovations are underway to industrialize cell and gene therapies

Thursday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST
Sponsor
Revolutionary innovations are underway to industrialize cell and gene therapies

An exploration of the challenges in the cell and gene therapy space today is necessary due to the unique complexity of CGTs compared to other biologic modalities.

In this discussion, we will explore the complex landscape of process development and analytical development, while reviewing key focus areas based on lessons learned across our experiences. The discussion will be framed around where the market is headed and how breakthroughs will make for a bright future.

  • The critical importance of considering process development early on
  • The benefits of reducing manual and open processing
  • Standardized approaches and processes for scalable manufacturing in addition to standardized analytics and consumables wherever possible
  • The importance of people and quality systems
Mark Santos
Mark Santos
Global Head of Commercial Development & Marketing, Cell & Gene Technologies at Lonza

Mark is the commercial and marketing lead for Lonza’s CGT Business unit. His responsibilities include promoting & designing Lonza’s CGT offerings and capabilities. This includes strategic relationships, investment prioritization and offerings within Lonza’s CGT business to result in high value partnerships.

Mark has 15+ years of experience in the Biopharmaceutical space. He currently lives in the United States. Previously he was in Switzerland to help build the Strategic and Innovation roadmap for Lonza’s Bioconjugate business unit. He has led the development and delivery of multiple large investment projects across mammalian, bioconjugate and vaccine technologies. He worked for PwC Pharma R&D Ops to help transform business & operational planning for large pharmaceutical organizations. His career started in mammalian and microbial manufacturing.

Mark has a Masters in Business Administration & a Microbial degree from the University of New Hampshire.

in 25
Days

SPEAKERS

Mark Santos
Mark Santos
Global Head of Commercial Development & Marketing, Cell & Gene Technologies at Lonza

You might also like

Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME

Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME

Emily Neil, Ariadna Pascual
27 June
in 39
Days
Register
End-to-end automated manufacturing of low-seed CAR-T cells

End-to-end automated manufacturing of low-seed CAR-T cells

David Smith
27 June
in 39
Days
Register
Discover the road to success for viral vector production: strategies, insights, and regulatory considerations

Discover the road to success for viral vector production: strategies, insights, and regulatory considerations

S Shore, A Gilbert, J Bishop
20 June
in 32
Days
Register
Specifications don’t tell the whole story: how to choose GMP process and QC equipment

Specifications don’t tell the whole story: how to choose GMP process and QC equipment

M Kay Bates, W Marin, K Whitlatch
18 June
in 30
Days
Register
Process optimization of mRNA purification for vaccines and therapeutic applications

Process optimization of mRNA purification for vaccines and therapeutic applications

Chantelle Gaskin
13 June
in 25
Days
Register